The Science of Health
Purdue University is making a $250 million investment in the life sciences over the next five years. This investment will spur increased opportunities to coalesce and strengthen Purdue’s impact on global health.
Basic advances working across disciplinary boundaries are advancing drug discoveries; deepening our understanding of inflammation, immunology and infectious diseases; unraveling the mysteries of the healthy brain to alleviate suffering associated with nervous system trauma and disease; and developing new diagnostic tools – turning implantable devices into therapeutic delivery systems and imaging technologies into real-time analytical surgical instruments.
Scholars working on the science of health are focusing attention in the following areas.
We are coming up with treatments for cancer, Alzheimer's, heart disease, and infectious diseases such as malaria and HIV. Roughly 40 Purdue-developed drugs are in the pipeline for FDA approval. Two drugs have been approved and 15 are in human trials.
Inflammation, Immunology and Infectious Disease
Ongoing research and discoveries in inflammation, immunology and infectious disease brings the power of a major research institution like Purdue along with their partners to create solutions to health problems that plague Americans and people around the globe.
Scholars in integrative neuroscience are unraveling the mysteries of the healthy brain to alleviate suffering associated with nervous system trauma and disease. Key areas include aging and neurodegeneration, neurotrauma and neuropathology, development genetics and neuropharmacology, and innovative technologies in brain and behavior.
Implantable devices are being developed as innovative drug delivery systems and as novel diagnostic tools.
Imaging technologies enhance real-time diagnostics in surgical environments and advancing our understanding of the biological processes associated with disease and our health.